Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

被引:4
|
作者
Li, Hongqing [1 ]
Guo, Wenqin [1 ]
Dai, Weiran [1 ]
Li, Lang [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangxi Cardiovasc Inst, Nanning 530021, Guangxi, Peoples R China
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2018年 / 12卷
关键词
dual antiplatelet therapy; second-generation drug-eluting stent implantation; meta-analysis; CORONARY-ARTERY-DISEASE; FOCUSED UPDATE; CLINICAL-TRIAL; DURATION; CLOPIDOGREL; EFFICACY; DISCONTINUATION; MULTICENTER; 6-MONTH; SAFETY;
D O I
10.2147/DDDT.S165435
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The optimal dual antiplatelet therapy (DAPT) duration after second-generation drug-eluting stent (DES) implantation remains unclear. We aim to evaluate the efficacy and safety of short-term (<= 6 months) and long-term (>= 12 months) DAPT after second-generation DES implantation. Methods: Randomized controlled trials (RCTs) were searched in PubMed, the Cochrane Library, the Embase and ClinicalTrials.gov in the English language. The endpoints included all-cause mortality, cardiac death, non-cardiac death, myocardial infarction (MI), stent thrombosis (ST), stroke, all bleeding, and major bleeding. The effect estimate was expressed by using the hazard ratio (HR) with 95% CI and random effect models. Results: Seven RCTs with 13,571 patients were included in this study. In terms of survival endpoints, there was no significant difference in all-cause mortality (HR: 0.91; 95% CI: 0.71-1.17), cardiac death (HR: 0.93; 95% CI: 0.67-1.29), and non-cardiac death (HR: 0.89; 95% CI: 0.62-1.28) in the 2 groups. Moreover, there was no significant difference in ischemic outcomes, including MI (HR: 1.15; 95% CI: 0.91-1.45), ST (HR: 1.11; 95% CI: 0.75-1.66), and stroke (HR: 0.85; 95% CI: 0.53-1.35) in the 2 groups. In terms of bleeding endpoints, there was no significant difference in all bleeding (HR: 0.81; 95% CI: 0.64-1.04) and major bleeding (HR: 0.82; 95% CI: 0.49-1.36) in the 2 groups. The subgroup analysis showed that the proportion of patients with acute coronary syndrome was not associated with the benefit of long-term versus short-term DAPT. Conclusion: Short-term DAPT is not inferior to long-term DAPT in patients implanted with second-generation DES.
引用
收藏
页码:1815 / 1825
页数:11
相关论文
共 50 条
  • [21] Short Versus Long Duration of Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stents Implantation in Patients with Diabetes
    Gangwani, Manesh Kumar
    Aziz, Muhammad
    Chacko, Paul
    Mahmood, Asif
    Ali, Muhammad
    Priyanka, Fnu
    Munir, Siraj
    Aziz, Abeer
    Sagheer, Shazib
    Lee-Smith, Wade
    Parkash, Om
    Rai, Devesh
    Baibhav, Bipul
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (05) : E416 - E425
  • [22] Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials
    Tsoi, Man-Fung
    Cheung, Ching-Lung
    Cheung, Tommy Tsang
    Wong, Ian Chi-Kei
    Kumana, Cyrus Rustam
    Tse, Hung-Fat
    Cheung, Bernard Man-Yung
    SCIENTIFIC REPORTS, 2015, 5
  • [23] Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials
    Zou, Yandun
    Hu, Chunling
    Ye, Wenhui
    Fan, Limei
    Xu, Likun
    Zhang, Aidong
    THROMBOSIS RESEARCH, 2015, 136 (05) : 870 - 877
  • [24] Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials
    Man-Fung Tsoi
    Ching-Lung Cheung
    Tommy Tsang Cheung
    Ian Chi-Kei Wong
    Cyrus Rustam Kumana
    Hung-Fat Tse
    Bernard Man-Yung Cheung
    Scientific Reports, 5
  • [25] Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis Foreword
    Marmur, Jonathan D.
    Sharma, Abhishek
    CURRENT PROBLEMS IN CARDIOLOGY, 2017, 42 (12) : 402 - 403
  • [26] Short-term vs long-term dual antiplatelet therapy after drug-eluting stent implantation in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
    Li, Jingxin
    He, Ke
    Ge, Jun
    Li, Caixia
    Jing, Zeng
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [27] Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: An update Meta-Analysis of Current Randomized Controlled Trials
    Lu, Zhang
    Yu, Xiaoping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C167 - C168
  • [28] Meta-Analysis of Randomized Clinical Trials Comparing Short-Term Versus Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents
    El-Hayek, Georges
    Messerli, Franz
    Bangalore, Sripal
    Hong, Mun K.
    Herzog, Eyal
    Benjo, Alexandre
    Tamis-Holland, Jacqueline E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (02): : 236 - 242
  • [29] Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials
    Zhao, Shijie
    Zhong, Zhaoshuang
    Qi, Guoxian
    Shi, Liye
    Tian, Wen
    CLINICAL DRUG INVESTIGATION, 2019, 39 (01) : 1 - 13
  • [30] Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials
    Shijie Zhao
    Zhaoshuang Zhong
    Guoxian Qi
    Liye Shi
    Wen Tian
    Clinical Drug Investigation, 2019, 39 : 1 - 13